1 / 1

DECREASE III

DECREASE III. Myocardial ischemia was significantly reduced with statin ( OR 0.53; 95% CI 0.32-0.88, p = 0.016) LDL (p < 0.001) and hs-CRP (p  0.001) were lower in statin arm Incidence of adverse events was similar. (p = 0.016). (p = 0.039). Fluvastatin XL (n = 250). Placebo

tab
Télécharger la présentation

DECREASE III

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. DECREASE III Myocardial ischemia was significantly reduced with statin (OR 0.53; 95% CI 0.32-0.88, p = 0.016) LDL (p < 0.001) and hs-CRP (p  0.001) were lower in statin arm Incidence of adverse events was similar (p = 0.016) (p = 0.039) Fluvastatin XL (n = 250) Placebo (n = 247) Trial design: Patients undergoing noncardiac vascular surgery were randomized to fluvastatin XL or placebo, in addition to beta-blockers. Clinical outcomes were compared at 1 month. Results 19.0 20 20 15 15 Conclusions 10.9 % % 10.1 10 10 • Perioperative statin therapy was associated with improved outcomes in high-risk patients undergoing noncardiac vascular surgery • Results add to current literature on the benefit of statins in the perioperative period 4.8 5 5 0 0 Myocardial ischemia CV death or MI Presented by Dr. Don Poldermans at ESC 2008

More Related